The Nocebo Effect

被引:17
|
作者
Colloca, Luana [1 ,2 ]
机构
[1] Univ Maryland, Dept Pain & Translat Symptom Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Nursing, Placebo Opin Ctr, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
negative outcomes; expectancy; discontinuation; framing effects; nonadherence; learning; side effects; MU-OPIOID RECEPTOR; PLACEBO GROUPS; NONCONSCIOUS ACTIVATION; SOCIAL OBSERVATION; HEALTH COMPLAINTS; CLINICAL-TRIALS; ADVERSE EVENTS; WIND TURBINES; CHRONIC PAIN; SPINAL-CORD;
D O I
10.1146/annurev-pharmtox-022723-112425
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse nocebo responses can cause harm to patients and interfere with treatment adherence and effects in both clinic practice and clinical trials. Nocebo responses refer to negative outcomes to active medical treatments in clinical trials or practice that cannot be explained by the treatment's pharmacologic effects. Negative expectancies and nocebo effects are less known than placebo responses. Nocebo effects can be triggered by verbal suggestions, prior negative experiences, observation of others experiencing negative outcomes, and other contextual and environmental factors. As research advances over the years, mechanistic knowledge is accumulating on the neurobiological mechanisms of nocebo effects. This review summarizes studies on different facets of nocebo effects and responses and discusses clinical implications, ethical considerations, and future directions.
引用
收藏
页码:171 / 190
页数:20
相关论文
共 50 条
  • [41] From nocebo effect to the hypothesis of nocebo comparison and psychometric tests as entry criteria in headache trials
    Nicolodi, M.
    Torrini, A.
    CEPHALALGIA, 2009, 29 : 39 - 39
  • [42] Nocebo effect of Covid-19 vaccines
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Ruelle, Yannick
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2022, (181): : 144 - 144
  • [43] PATIENT INFLUENCE ON BIOSIMILAR UPTAKE: THE NOCEBO EFFECT
    Povsic, M.
    Lavelle, P.
    Enstone, A.
    Rousseau, B.
    VALUE IN HEALTH, 2018, 21 : S181 - S181
  • [44] Lurid Coverage fueled Nocebo-Effect
    不详
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2013, 56 (03): : 34 - 34
  • [45] Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect
    Mourad F. Rezk
    Burkhard Pieper
    Rheumatology and Therapy, 2017, 4 : 209 - 218
  • [46] The Nocebo Effect: A Review of Contemporary Experimental Research
    Branka Bagarić
    Nataša Jokić-Begić
    Claire Sangster Jokić
    International Journal of Behavioral Medicine, 2022, 29 : 255 - 265
  • [47] SAMSON and the Nocebo Effect: Management of Statin Intolerance
    Krishnamurthy, Amrita
    Bradley, Corey
    Ascunce, Rebecca
    Kim, Samuel M.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (09) : 1101 - 1108
  • [48] Using Learning Strategies to Inhibit the Nocebo Effect
    Quinn, Veronica F.
    Colagiuri, Ben
    NEUROBIOLOGY OF THE PLACEBO EFFECT, PT I, 2018, 138 : 307 - 327
  • [49] The nocebo effect: a clinical challenge in the era of biosimilars
    Pouillon, Lieven
    Socha, Marie
    Demore, Beatrice
    Thilly, Nathalie
    Abitbol, Vered
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (09) : 739 - 749
  • [50] The Nocebo Effect: A Review of Contemporary Experimental Research
    Bagaric, Branka
    Jokic-Begic, Natasa
    Sangster Jokic, Claire
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2022, 29 (03) : 255 - 265